Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06874283 · ClinicalTrials.gov registry record
Ocular Complications From Cancer Therapy - Patient Registry and Biobank
A clinical trial of Graft Versus Host Disease in Eye and Ocular Complications, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06874283 is a study of Graft Versus Host Disease in Eye and Ocular Complications that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06874283, a study of Graft Versus Host Disease in Eye and Ocular Complications, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect data on patients seen at University of Maryland after undergoing cancer therapy. Previous medications, ocular history, medical history, clinical evaluations, surgical procedures and outcomes will be gathered on the patients who consent to participate. Potential subjects will be enrolled from the clinical practice of the investigator at the time of their eye examination visit. A standard of care exam will be performed pertinent to the reason for the visit. In addition to the standard of care exam, certain biological specimens (ocular surface wash, mucocellular material, corneal filaments, impression cytology, and/or blood) will be collected, stored, and analyzed to obtain immunologic, cellular, or molecular mechanistic insights into disease pathogenesis.
Conditions Studied
Interventions
- PROCEDURE Eye exam
Study Locations (1)
Maryland
- Stoler Outpatient Cancer Center at the University of Maryland - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-05-13 |
| Est. Completion | 2031-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06874283
The ClinicalTrials.gov registry entry for NCT06874283 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Graft Versus Host Disease in Eye appearing as the primary indexed condition, and to 1 intervention - of which Eye exam is the first listed.
NCT06874283 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06874283 about?
NCT06874283 is a clinical study titled "Ocular Complications From Cancer Therapy - Patient Registry and Biobank". The purpose of this study is to collect data on patients seen at University of Maryland after undergoing cancer therapy. Previous medications, ocular history, medical history, clinical evaluations, surgical procedures and outcomes will be gathered on the patients who consent to participate. Potentia...
What is the current status of trial NCT06874283?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-05-13. Estimated completion is 2031-04.
What conditions does trial NCT06874283 study?
This clinical trial studies the following conditions: Graft Versus Host Disease in Eye, Ocular Complications, Inflammatory Dry Eye Disease.
What interventions are being tested in trial NCT06874283?
The interventions under investigation include: Eye exam (PROCEDURE).
Who is sponsoring clinical trial NCT06874283?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06874283 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.